A detailed history of Aviva PLC transactions in Bio Techne Corp stock. As of the latest transaction made, Aviva PLC holds 5,774 shares of TECH stock, worth $421,675. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,774
Previous 5,792 0.31%
Holding current value
$421,675
Previous $414,000 11.35%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$70.96 - $82.35 $1,277 - $1,482
-18 Reduced 0.31%
5,774 $461,000
Q2 2024

Aug 02, 2024

SELL
$62.12 - $84.15 $1,987 - $2,692
-32 Reduced 0.55%
5,792 $414,000
Q1 2024

May 14, 2024

SELL
$65.98 - $77.09 $923 - $1,079
-14 Reduced 0.24%
5,824 $409,000
Q4 2023

Feb 09, 2024

SELL
$52.83 - $78.22 $435,794 - $645,236
-8,249 Reduced 58.56%
5,838 $450,000
Q3 2023

Nov 13, 2023

SELL
$67.52 - $89.42 $609,975 - $807,820
-9,034 Reduced 39.07%
14,087 $958,000
Q2 2023

Aug 10, 2023

SELL
$73.76 - $85.98 $10 Million - $11.7 Million
-135,934 Reduced 85.46%
23,121 $1.89 Million
Q1 2023

May 12, 2023

BUY
$71.62 - $86.62 $9.01 Million - $10.9 Million
125,740 Added 377.43%
159,055 $11.8 Million
Q4 2022

Feb 09, 2023

BUY
$80.67 - $352.29 $1.86 Million - $8.12 Million
23,037 Added 224.14%
33,315 $2.76 Million
Q3 2022

Nov 14, 2022

SELL
$282.54 - $391.85 $1.88 Million - $2.6 Million
-6,642 Reduced 39.26%
10,278 $2.92 Million
Q2 2022

Aug 04, 2022

SELL
$322.67 - $449.65 $121,969 - $169,967
-378 Reduced 2.19%
16,920 $5.87 Million
Q1 2022

May 13, 2022

BUY
$353.85 - $487.79 $549,175 - $757,050
1,552 Added 9.86%
17,298 $7.49 Million
Q4 2021

Feb 10, 2022

BUY
$456.15 - $525.06 $1.79 Million - $2.06 Million
3,915 Added 33.09%
15,746 $8.15 Million
Q3 2021

Nov 12, 2021

BUY
$444.87 - $538.88 $2.92 Million - $3.54 Million
6,566 Added 124.71%
11,831 $5.73 Million
Q2 2021

Aug 10, 2021

BUY
$387.35 - $450.26 $791,743 - $920,331
2,044 Added 63.46%
5,265 $2.37 Million
Q1 2021

May 13, 2021

SELL
$314.62 - $411.0 $615,711 - $804,327
-1,957 Reduced 37.79%
3,221 $1.23 Million
Q4 2020

Feb 10, 2021

SELL
$246.9 - $321.87 $1.04 Million - $1.35 Million
-4,197 Reduced 44.77%
5,178 $1.64 Million
Q3 2020

Nov 12, 2020

BUY
$232.22 - $282.96 $87,779 - $106,958
378 Added 4.2%
9,375 $2.32 Million
Q2 2020

Aug 13, 2020

SELL
$185.43 - $279.56 $2 Million - $3.01 Million
-10,760 Reduced 54.46%
8,997 $2.38 Million
Q1 2020

May 14, 2020

BUY
$161.17 - $221.51 $1.79 Million - $2.46 Million
11,085 Added 127.83%
19,757 $3.75 Million
Q4 2019

Feb 10, 2020

BUY
$189.68 - $222.09 $1.64 Million - $1.93 Million
8,672 New
8,672 $1.9 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.86B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.